US$ 29.61
melanotic schwannoma sarcoma Pathology Outlines Frontiers | Case Report: Anlotinib
Description
Therapy is ordinarily continued for 12 to 16 weeks before reassessment

ASCO Meeting(abstract 1659)

1 tablet contains: Active substance: cabergoline 500 mcg
Medical treatments that increase risk of skin cancer Some medical treatments which use UV radiation may increase the risk of skin cancer
